163 related articles for article (PubMed ID: 5125476)
21. Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.
Benkert O; Gluba H; Matussek N
Neuropharmacology; 1973 Mar; 12(3):177-86. PubMed ID: 4735415
[No Abstract] [Full Text] [Related]
22. Role of brain norepinephrine in audiogenic seizure in the rat.
Jobe PC; Picchioni AL; Chin L
J Pharmacol Exp Ther; 1973 Jan; 184(1):1-10. PubMed ID: 4686009
[No Abstract] [Full Text] [Related]
23. The occurrence of biogenic monoamines in the mammalian endocrine pancreas.
Cegrell L
Acta Physiol Scand Suppl; 1968; 314():1-60. PubMed ID: 4973243
[No Abstract] [Full Text] [Related]
24. Norepinephrine and dopamine in the developing chick brain.
Kobayashi K; Eiduson S
Dev Psychobiol; 1970; 3(1):13-34. PubMed ID: 4146802
[No Abstract] [Full Text] [Related]
25. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
Bartholini G; Blum JE; Pletscher A
J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
[No Abstract] [Full Text] [Related]
26. Effect of acylation with eleostearic acids on the monoamine oxidase inhibitory potency of some hydrazine antidepressants in mice.
Hsu SY; Huang CL; Waters IW
J Med Chem; 1975 Jan; 18(1):20-3. PubMed ID: 1109570
[TBL] [Abstract][Full Text] [Related]
27. Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests.
Horst WD; Pool WR; Spiegel HE
Eur J Pharmacol; 1973 Mar; 21(3):337-42. PubMed ID: 4736076
[No Abstract] [Full Text] [Related]
28. 4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo.
Porter CC; Torchiana ML
Biochem Pharmacol; 1971 Jan; 20(1):183-91. PubMed ID: 4398314
[No Abstract] [Full Text] [Related]
29. Behavioural and biochemical interaction between caffeine and L-dopa.
Strömberg U; Waldeck B
J Pharm Pharmacol; 1973 Apr; 25(4):302-8. PubMed ID: 4146682
[No Abstract] [Full Text] [Related]
30. Central 5-HTP decarboxylase inhibiting properties of Ro 4-4602 in relation to 5-HTP potentiation in mice.
Hyttel J; Fjalland B
Eur J Pharmacol; 1972 Jul; 19(1):112-4. PubMed ID: 4538041
[No Abstract] [Full Text] [Related]
31. Dopa-induced excitement in the cat. Its relationship to brain norepinephrine concentrations.
Reis DJ; Moorhead DT; Merlino N
Arch Neurol; 1970 Jan; 22(1):31-9. PubMed ID: 4391435
[No Abstract] [Full Text] [Related]
32. [Action of a decarboxylase inhibitor on endogenous plasmatic DOPA, in man].
Geissbuhler F; Constantinidis J; Gaillard JM; des Combes NJ; Tissot R
Biomedicine; 1974 Jul; 21(7):297-8. PubMed ID: 4433662
[No Abstract] [Full Text] [Related]
33. Studies on the mechanism of the L-3,4-dihydroxyphenylalanine-induced decrease in tyrosine hydroxylase activity.
Dairman W; Udenfriend S
Mol Pharmacol; 1972 May; 8(3):293-9. PubMed ID: 4402746
[No Abstract] [Full Text] [Related]
34. L-Dopa administration to neonate chicks: effects on behavior and levels of brain biogenic amines.
Hanig JP; Seifter J
Experientia; 1971 Feb; 27(2):168-9. PubMed ID: 5549261
[No Abstract] [Full Text] [Related]
35. On the localization of the hypotensive effect of L-dopa.
Henning M; Rubenson A; Trolin G
J Pharm Pharmacol; 1972 Jun; 24(6):447-51. PubMed ID: 4403826
[No Abstract] [Full Text] [Related]
36. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
Butcher LL; Engel J; Fuxe K
Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
[No Abstract] [Full Text] [Related]
37. Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.
Henning M; Rubenson A
J Pharm Pharmacol; 1970 Aug; 22(8):553-60. PubMed ID: 4394527
[No Abstract] [Full Text] [Related]
38. Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase.
Bartholini G; Constantinidis J; Tissot R; Pletscher A
Biochem Pharmacol; 1971 Jun; 20(6):1243-7. PubMed ID: 5315769
[No Abstract] [Full Text] [Related]
39. Some benzhydryl derivatives as central dopamine receptor stimulating agents.
van Beek MC; Timmerman H
J Pharm Pharmacol; 1974 Jan; 26(1):57-8. PubMed ID: 4150936
[No Abstract] [Full Text] [Related]
40. Distribution of DOPA-2- 14 C in relation to DOPA-1- 14 C (carboxyl- 14 C-labelled DOPA) in mice before and after inhibition of DOPA-decarboxylase, studied by whole-body autoradiography.
Tjälve H; Ullberg S
Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):376-88. PubMed ID: 4627124
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
